Skip to main content
Commentary

Recommendations and low-technology safety solutions following neuromuscular blocking agent incidents.

Graudins L, Downey G, Bui T, et al. Recommendations and Low-Technology Safety Solutions Following Neuromuscular Blocking Agent Incidents. Jt Comm J Qual Patient Saf. 2016;42(2)(2):86-91.

Save

Print

February 3, 2016
Graudins L, Downey G, Bui T, et al. Jt Comm J Qual Patient Saf. 2016;42(2):86-91.

Administration errors involving high-alert medications have the potential to cause serious patient harm. This commentary discusses one hospital's effort to reduce errors associated with neuromuscular blocking agents. The authors used root cause analysis to identify weaknesses in labeling, storage, and packaging methods, and implemented guidelines to reduce risk of errors involving such medications.

Save

Print

Cite
Citation

Graudins L, Downey G, Bui T, et al. Recommendations and Low-Technology Safety Solutions Following Neuromuscular Blocking Agent Incidents. Jt Comm J Qual Patient Saf. 2016;42(2)(2):86-91.